BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent  Yahoo Finance

Initiation of Phase One Clinical Studies Expected This Year ANN ARBOR, Mich. , May 29, 2019 /PRNewswire/ — BlueWillow Biologics ® today announced the …